416 related articles for article (PubMed ID: 21266664)
41. The effects of ergot and non-ergot-derived dopamine agonists in an experimental mouse model of endometriosis.
Delgado-Rosas F; Gómez R; Ferrero H; Gaytan F; Garcia-Velasco J; Simón C; Pellicer A
Reproduction; 2011 Nov; 142(5):745-55. PubMed ID: 21862695
[TBL] [Abstract][Full Text] [Related]
42. Green tea epigallocatechin-3-gallate inhibits angiogenesis and suppresses vascular endothelial growth factor C/vascular endothelial growth factor receptor 2 expression and signaling in experimental endometriosis in vivo.
Xu H; Becker CM; Lui WT; Chu CY; Davis TN; Kung AL; Birsner AE; D'Amato RJ; Wai Man GC; Wang CC
Fertil Steril; 2011 Oct; 96(4):1021-8. PubMed ID: 21821246
[TBL] [Abstract][Full Text] [Related]
43. Antiangiogenic therapy of head and neck squamous cell carcinoma by vascular endothelial growth factor antisense therapy.
Riedel F; Götte K; Hörmann K; Grandis JR
Adv Otorhinolaryngol; 2005; 62():103-20. PubMed ID: 15608422
[TBL] [Abstract][Full Text] [Related]
44. Influence of non-toxic doses of bevacizumab and ranibizumab on endothelial functions and inhibition of angiogenesis.
Barzelay A; Lowenstein A; George J; Barak A
Curr Eye Res; 2010 Sep; 35(9):835-41. PubMed ID: 20795866
[TBL] [Abstract][Full Text] [Related]
45. Molecular basis of the synergistic antiangiogenic activity of bevacizumab and mithramycin A.
Jia Z; Zhang J; Wei D; Wang L; Yuan P; Le X; Li Q; Yao J; Xie K
Cancer Res; 2007 May; 67(10):4878-85. PubMed ID: 17510417
[TBL] [Abstract][Full Text] [Related]
46. Change of proinflammatory cytokines follows certain patterns after induction of endometriosis in a mouse model.
Chen QH; Zhou WD; Su ZY; Huang QS; Jiang JN; Chen QX
Fertil Steril; 2010 Mar; 93(5):1448-54. PubMed ID: 19342044
[TBL] [Abstract][Full Text] [Related]
47. 2-methoxyestradiol in the pathophysiology of endometriosis: focus on angiogenesis and therapeutic potential.
Machado-Linde F; Pelegrin P; Sanchez-Ferrer ML; Leon J; Cascales P; Parrilla JJ
Reprod Sci; 2012 Oct; 19(10):1018-29. PubMed ID: 22875846
[TBL] [Abstract][Full Text] [Related]
48. Inhibitory effect of thalidomide on the growth, secretory function and angiogenesis of estrogen-induced prolactinoma in Fischer 344 rats.
Stepień H; Lawnicka H; Mucha S; Wagrowska-Danilewicz M; Stepień B; Siejka A; Komorowski J
Life Sci; 2006 Sep; 79(18):1741-8. PubMed ID: 16846617
[TBL] [Abstract][Full Text] [Related]
49. Impact of Bevacizumab on Experimentally Induced Endometriotic Lesions: Angiogenesis, Invasion, Apoptosis, and Cell Proliferation.
Zani ACT; Valerio FP; Meola J; da Silva AR; Nogueira AA; Candido-Dos-Reis FJ; Poli-Neto OB; Rosa-E-Silva JC
Reprod Sci; 2020 Oct; 27(10):1943-1950. PubMed ID: 32542537
[TBL] [Abstract][Full Text] [Related]
50. [Study of tissue morphology and vascular endothelial growth factor and matrix metalloproteinase-9 gene expressions in nude mouse endometriosis model].
Wang DB; Zhang SL; Niu HY; Lu JM
Zhonghua Fu Chan Ke Za Zhi; 2004 Nov; 39(11):759-62. PubMed ID: 15634503
[TBL] [Abstract][Full Text] [Related]
51. [Expression of vascular endothelial growth factor in the peritoneal fluid and eutopic endometrium of patients with endometriosis].
Fang XL; Xia XM; Lin QH
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):288-90. PubMed ID: 14653093
[TBL] [Abstract][Full Text] [Related]
52. Effect of GnRHa on apoptosis and release of VEGF in endometrial cell cultures from patients with adenomyosis.
Xiao-xia W; Jia-li K; Xue-fei S; Jia Y; Ling-hong D
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jan; 28(1):72-3. PubMed ID: 22512052
[TBL] [Abstract][Full Text] [Related]
53. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.
Machado DE; Berardo PT; Landgraf RG; Fernandes PD; Palmero C; Alves LM; Abrao MS; Nasciutti LE
Fertil Steril; 2010 May; 93(8):2674-9. PubMed ID: 20056215
[TBL] [Abstract][Full Text] [Related]
54. Epigallocatechin-3-gallate inhibits estrogen-induced activation of endometrial cells in vitro and causes regression of endometriotic lesions in vivo.
Laschke MW; Schwender C; Scheuer C; Vollmar B; Menger MD
Hum Reprod; 2008 Oct; 23(10):2308-18. PubMed ID: 18603648
[TBL] [Abstract][Full Text] [Related]
55. [Therapeutic effects of Avastin on the murine hemangioendothelioma].
Xu ZQ; Liu Y; Wang YX; Zhang W; Zhao FY
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Feb; 41(1):105-8. PubMed ID: 19221576
[TBL] [Abstract][Full Text] [Related]
56. In vitro effects of bevacizumab treatment on newborn rat retinal cell proliferation, death, and differentiation.
Miguel NC; Matsuda M; Portes AL; Allodi S; Mendez-Otero R; Puntar T; Sholl-Franco A; Krempel PG; Monteiro ML
Invest Ophthalmol Vis Sci; 2012 Nov; 53(12):7904-11. PubMed ID: 23139275
[TBL] [Abstract][Full Text] [Related]
57. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
58. A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis xenografts via antiangiogenic activity in severe combined immunodeficiency mice.
Ozawa Y; Murakami T; Tamura M; Terada Y; Yaegashi N; Okamura K
Fertil Steril; 2006 Oct; 86(4 Suppl):1146-51. PubMed ID: 16962108
[TBL] [Abstract][Full Text] [Related]
59. Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma.
Huynh H; Chow PK; Palanisamy N; Salto-Tellez M; Goh BC; Lee CK; Somani A; Lee HS; Kalpana R; Yu K; Tan PH; Wu J; Soong R; Lee MH; Hor H; Soo KC; Toh HC; Tan P
J Hepatol; 2008 Jul; 49(1):52-60. PubMed ID: 18490075
[TBL] [Abstract][Full Text] [Related]
60. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production.
Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP
Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
